/ WHO WE ARE
RiverVest is a leading venture capital firm building life science companies to address significant unmet medical needs.
8
FUNDS
Since 2000
/ EXPERT INSIGHT
RiverVest speaks with Lyn Baranowski, CEO of portfolio company Avalyn Pharma, about who she is, what brought her to Avalyn, and what fuels her passion for building great companies.
/ NEWS
ST. LOUIS, December 14, 2023 – RiverVest Venture Partners today announced the promotions of three current team members: Karen Spilizewski and Izaac Zike, Ph.D. to Managing Director and Pascal Krotee, Ph.D. to Principal.
/ EXPERT INSIGHT
RiverVest speaks with Vikram Sudarsan, PhD, founder and CEO of Engrail Therapeutics about the company’s novel approach to addressing a significant, unmet mental health need.
27
COMMERCIAL PRODUCTS
Currently Treating Patients
RiverVest strives to improve the lives of patients, support entrepreneurs, and earn the trust of investors through science, strategy, and innovation.
Contact us at info@rivervest.com
Transparency in Coverage Rule: To access the machine-readable files created and published by United Healthcare, please click here.
© Copyright 2024 RiverVest® All Rights Reserved. | Privacy Policy
Subscribe to our newsletter